Patients with autoimmune diseases are among the susceptible groups to COVID-19
infection because of the complexity of their conditions and the side effects of the …

Vaccination against COVID-19 is vital for achieving herd immunity, and the Government of
India has adopted several strategies to achieve coverage. Vaccine hesitancy was identified …

Objectives We aimed to investigate the role of rheumatoid arthritis (RA) with biologic or
targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID …

Background: After the start of the worldwide COVID-19 vaccination campaign, there were
increased reports of autoimmune diseases occurring de novo after vaccination. This in silico …

Objective Flares of autoimmune rheumatic diseases (AIRDs) following COVID-19
vaccination are a particular concern in vaccine-hesitant individuals. Therefore, we …

Objective To determine COVID-19 vaccine-related adverse events (AEs) in the seven-day
post-vaccination period in patients with SLE vs autoimmune rheumatic diseases (AIRDs) …

Objective Disparities in COVID‐19 vaccine and booster uptake persist. This study aimed to
obtain perspectives from community and physician stakeholders on COVID‐19 vaccine and …

Background Patients with autoimmune and immune-mediated diseases (AI-IMD) are at
greater risk of COVID-19 infection; therefore, they should be prioritized in vaccination …

The attitudes toward emerging COVID-19 vaccines have been of great interest worldwide,
especially among vulnerable populations such as patients with rheumatic and …

Objective The causalities between the coronavirus disease 2019 (COVID‐19) and the risk of
rheumatic diseases remain unclear. The purpose of this study was to investigate the causal …